Fig. 3
From: ARL3 is downregulated and acts as a prognostic biomarker in glioma
Nomogram for predicting 3 or 5-year survival in glioma patients. The top row shows the point value for each variable. Rows 2–6 indicate the variables included in the nomogram. Each variable corresponds to a point value based on glioma characteristics. The sum of these values is located on the Total Points axis, and the line drawn downward to the survival axes is used to determine the likelihood of 3- or 5-year survival. ARL3 was represented as the mRNA expression level in RNA-seq with log2 transformation